Similar Articles |
|
Pharmaceutical Executive September 1, 2006 |
Sewing Up New Sales Simple, elegant lines are the backbone of any good design, including a new sales model. Get that right, and your model can be tailored to fit any customer. |
Pharmaceutical Executive October 1, 2005 Mike Iafolla & Steve Greco |
Under the Influence The number of influences that affect physicians' prescribing has increased and rep saturation has reached the tipping point, resulting in "customer fatigue." Companies must now take into account a plethora of influences when planning their sales and marketing efforts. |
Pharmaceutical Executive March 1, 2009 Brittany Agro |
The New Sales Force The arms race is over, and it's time to reinvent pharma sales. Here's what forward-looking companies are experimenting with, and how it's working. |
Pharmaceutical Executive May 1, 2006 Musacchio & Hunkler |
More Than a Game of Keep Away The Prescribing Data Restriction Program takes effect in July. The AMA explains how individual doctors can keep their prescribing habits safe from reps, and how pharma can keep using the anonymous data -- if the industry polices itself. |
Pharmaceutical Executive July 1, 2011 Cabacungan & Clark |
New Ways to Gain New Brand Insights If you can learn to understand patient and physician behavior, you are well on your way to strengthening the position of your product. |
Pharmaceutical Executive January 1, 2007 Jeffrey Zornitsky |
Sales Management: Get Committed By better managing relationships with physicians, pharma companies can develop a base of dedicated prescribers. |
Pharmaceutical Executive March 1, 2012 Paolo De Marino |
Registering Value: Always in the Eye of the Beholder The organizational disconnect between marketing and market access is curable if both groups focus on what counts: who's making the final purchase. |
Pharmaceutical Executive June 1, 2005 Patrick Burns |
Sales Management: A Sample Plan One of the pharma industry's most important promotional tools is also one of its least understood. Here are new approaches to measuring the impact of sampling--and giving reps the tools they need to use samples better. |
Pharmaceutical Executive November 1, 2008 Tousi & Lee |
Making Sense of Sales The direct sales force is one of the largest costs for most pharma companies, but don't throw out sales force effectiveness with the sales force when cutting costs. Read on for some sure-fire strategies. |
Pharmaceutical Executive May 1, 2012 |
The Personal Touch in Digital Promotion The shift from sales rep meetings to digital selling methods must include innovation and a physician-centered mindset in order to be successful. |
Pharmaceutical Executive April 1, 2006 David Duplay |
Marketing to Professionals: A Sample Plan Sure, pharmaceutical e-sampling can save money. But there are plenty of other reasons to use it. |
Pharmaceutical Executive May 1, 2005 Jason Hogg |
Marketing to Professionals: Diagnosing MD Behavior A centralized database allows pharma marketers to truly know doctors. |
Pharmaceutical Executive October 1, 2011 |
Arming up for the Digital Revolution As a longtime advocate of new approaches to meeting customer needs in pharma, Martin Wygod sees the biggest change as the coming growth of digital platforms as the principal source of information and communication in healthcare. |
Pharmaceutical Executive October 1, 2012 Gregg DiPietro |
Reforming Pharma Marketing With respect to targeting, positioning, and launching new drugs, the ACA reform stands for Adjust, Change, and Adapt. |
Pharmaceutical Executive February 1, 2006 Nappi & Rodgers |
Marketing to Professionals: Streamlined Scheduling Better scheduling of sales visits can increase doctors' receptivity to pharmaceutical reps. |
Pharmaceutical Executive February 1, 2014 Anbil et al. |
Managed Markets: Positioning Your Product For Success with Pull Through Strategies A patient-centric approach to drug development delivers the benefits that actually create value |
Pharmaceutical Executive June 1, 2007 Breitstein & Armstrong |
Fixing the Sales Model Pharma's new commercialization strategy is, uh, in the works. But what did you expect? Getting it right takes time. |
Pharmaceutical Executive June 1, 2005 Zimmerman & Fay |
Marketing to Professionals: Dr. Ambassador The pharma industry is under siege in the news media. Smart companies must create a role for physicians as ambassadors who can raise patient confidence in drugs and the pharma industry as a whole. |
Pharmaceutical Executive June 1, 2005 Boschwitz et al. |
Track Patients, Not Prescriptions Why pharma companies reject anonymous patient-level data, and why they can't do without it for long. |
The Motley Fool September 15, 2011 Frank Vinluan |
GSK's New Drug Marketing Model: Pharma Reps As Educators, Not Sellers The conversation between sales reps and doctors today is vastly different compared to one year ago. |
Pharmaceutical Executive October 1, 2006 Scott Hull |
Back to the Future? Some states want to block access to doctor-level prescribing data. And the AMA helps members keep prescription records away from sales reps. An "old timer" remembers how he sold before databases came along. |
Pharmaceutical Executive May 1, 2009 |
Why All the Bad Buzz? European docs have always been down on pharma - but now the US is catching on. Perhaps pharma has oversold the "service model." |
Pharmaceutical Executive February 1, 2011 Scott Moldenhauer |
Accelerated Evolution Adapting training techniques for pharmaceutical sales representatives is necessary to thrive in the fact-changing dynamic of a physician's office |
Pharmaceutical Executive January 1, 2013 Torsten Bernewitz |
The Force Behind Sales Forces Don't underestimate the importance of the first line manager. |
CRM November 2009 Lauren McKay |
Pharmaceuticals -- CRM Undergoes an Experimental New Treatment An older CRM vertical gets a new dose of on-demand technology. |
Pharmaceutical Executive June 1, 2007 Jack Schember |
Sales Management: Cleaning House A well-maintained database is the key to maximum doctor outreach. |
Pharmaceutical Executive July 3, 2007 LeVine & Zucker |
Marketing to Professionals: Professional Promotion Through Patient Understanding Patient-feedback programs can go a long way in helping physicians understand which drugs work. |
Pharmaceutical Executive February 1, 2011 Stan Bernard |
Are You Trained to Compete and Win? With the impact of the sales rep in decline, it's time to beef up training for other pharma functions to fill the gap in a competitive marketplace |
Pharmaceutical Executive May 1, 2006 Stephen Wray |
Alternative Media: Interactive=Integration Interactive technology allows marketers to keep up with the demands of both physicians and consumers. |
BusinessWeek February 5, 2007 |
The Doctor Won't See You Now A host of forces is now converging to clamp down on hard-driving, gift-toting pharmaceutical pitchmasters who have been ambushing physicians for the last decade. |
CRM August 1, 2009 Lauren McKay |
The New Prescription for Pharma To address trends in the industry, pharmaceutical companies must do more with less and reshape their messages - not the easiest of tasks. |
Pharmaceutical Executive January 1, 2009 Stan Bernard |
Pharma vs. Pharma The most successful pharmaceutical companies will be those that can transform as the industry itself transforms. |
Pharmaceutical Executive January 1, 2013 Al Topin |
The Doctor-Patient Disconnect Doctor-patient conversations aren't always what we think; this basic interaction represents both a problem and an opportunity for today's drug marketers, says the author. |
Pharmaceutical Executive May 1, 2005 Sibyl Shalo |
Out to Lunch? For the average pharma rep, a 13-minute sales oriented meal trumps a 60-second office visit, any day of the week. |
Pharmaceutical Executive March 1, 2007 Jeffrey Zornitsky |
Sales Management: Get Committed By better managing relationships with physicians, pharma companies can develop a base of dedicated prescribers. |
Pharmaceutical Executive February 1, 2012 Wilcox et al. |
Sales Force Survey: Still Too Much Business as Usual? In the global battle for market share, the ability to adapt and mobilize your human assets around a responsive commercial model is a key variable of success. |
Pharmaceutical Executive March 1, 2006 Sharyn Lee |
Invisible Prescribers: What You Do and Don't Know About NPs and PAs How many prescriptions are written each year by nurse practitioners and physician assistants? Pharmaceutical companies not only fail to market to this sector, they neglect to invite nurse practitioners and physician assistants to meetings or to include them in plans for continuing medical education. |
Pharmaceutical Executive May 1, 2005 Manson & Katzenberg |
Unleash the Tablets In their rush to get tablet PCs into reps' hands, pharma companies can't forget one crucial step--training. |
Pharmaceutical Executive November 1, 2005 Mike Luby |
Marketing to Professionals: Detailing Attention to Details: The detail piece is a powerful sales tool when utilized and tested properly. |
CRM May 3, 2004 David Myron |
Vertical Focus: Pharmaceutical Firms Find a Spoonful of CRM Helps the Sales Pitch Go Down Ad campaigns create a pull-marketing effect, bringing patients into doctors' offices with product-specific questions. |
Pharmaceutical Executive May 1, 2007 Diane West |
Spend Trends 2007: Hang 10 Direct-to-Consumer Advertising Hits Its First Decade: Dr. Dot-Com... Digital Detailing... etc. |
Pharmaceutical Executive January 1, 2007 Davenport et al. |
Sales Slip Even before Pfizer blinked, companies were asking, "What ails sales?" In this annual survey, 50-plus pharmas and biotechs answer the hard questions about reps' productivity, profitability, and what to do about it. |
Pharmaceutical Executive September 1, 2005 Tenaglia & Angelastro |
No Margin for Error Pharmaceutical companies that will be forced to cut back on sales and marketing spending must focus on value, not volume. Here's how to reduce your spending where it matters the least. |
Pharmaceutical Executive June 1, 2006 Cindy D'Aoust |
Who's Coming to Meetings? Need to attract the "right" physicians to a promotional meeting? Have to do it on a budget while following new compliance rules? Check out this new survey to see how the rest of pharma lives with a shifting promotional landscape. |
Pharmaceutical Executive September 1, 2013 Shantanu Agrawal |
Making Sense of the Sunshine Act: A New Era for Drug Promotion Now that the Sunshine Act's Open Payments spending disclosure program is live, the federal government's lead officer for compliance explains how the new web-based system will work and how US industry, providers, and patients will be better off by making their relationships fully transparent. |
Pharmaceutical Executive June 1, 2012 Amy Smith |
Marketing: Medical Devices vs. Pharma Understanding the differences between drug and device marketing can make or break the brand's promotional activities. |
Pharmaceutical Executive October 1, 2008 Christian Marcazzo |
Remodeling Your Sales Force It's management makeover time and micromanaging is so last year. |
Pharmaceutical Executive April 1, 2011 David Quigley |
The Death of a Sales Model? These days, learning to strategically do more with less can keep your sales force performing at a high level. |
Pharmaceutical Executive September 1, 2008 Jeffrey S. Aronin |
The Orphan Opportunity The Orphan Drug Act was passed 25 years ago. But the challenge of actually getting rare disease drugs and therapies to patients still remains |
Pharmaceutical Executive September 1, 2010 Marylyn Donahue |
With a Little Help from their Peers Physician meetings drive prescribing behavior, but what are the marketing meetings doctors prefer, and who are they listening to? |